Revenue (¥ bn, bars) · net margin (%, line)
Source: securities reports
FY2011 · consolidated
Revenue$6.3B
Net income$117M
Net margin1.8%
→
FY2025 · consolidated
Revenue$4.1B
Net income$93M
Net margin2.3%
In April 2011 the holding company absorbed both operating companies and became an operating holding company itself, with consolidated sales of $5.7B (¥504bn) in its first full year. Earning power was the problem: the beverages and desserts segment, milk included, barely paid, and operating profit for the year to March 2015 was $88.8M (¥9bn) on a margin in the low single digits. Nishio Keiji, president from 2014, restructured that segment for a $33.1M (¥4bn) improvement inside a year and then shifted to investing in what worked. The two chosen fields were cheese and functional yoghurt: a Gasseri SP strain yoghurt was launched in 2015 as a Food with Function Claims on a visceral-fat reduction claim, and about $49.6M (¥6bn) went into a small-bottle drinking-yoghurt line at the Kyoto plant so that supply could finally keep up with the television and in-store promotion the company had been unable to run. With price revisions improving the mix, consolidated operating profit recovered to $173M (¥19bn) for the year to March 2018, and proprietary ingredients — MBP for bone metabolism, the Helve lactic acid bacterium — were built into a functional-foods business on the same pattern.
What would not improve was milk itself. A long-range vision drawn up in 2017 aimed at an operating margin near 5% and ROE above 8%; the 2019 medium-term plan’s $201.8M (¥22bn) operating profit target was missed at $165.1M (¥18bn) as yoghurt growth stalled and cheese prices were competed down, and the following plan’s goal of cutting the milk deficit by a third was missed too. Milk is hard to differentiate and easy to make a loss leader, so the red ink is structural rather than cyclical, and it could only be worked down slowly through line consolidation and item-by-item review. Through the pandemic — school and foodservice demand gone, household demand up, functional yoghurt spiking on immunity claims and then falling back — the company still held operating profit at $185.4M (¥20bn) for the year to March 2021, put about $65.6M (¥7bn) into a new string-cheese line at Taiki, took infant-formula maker Snow Brand Beanstalk fully in-house in 2021, and moved to the Tokyo Prime market in 2022.
Sato Masatoshi, president from 2021, made “the sustainability of food” the axis of the 2025 medium-term plan: in a country importing roughly 40% of its dairy, keeping supply stable is the company’s job, and a contribution-to-food-sustainability measure was written into how the portfolio is judged. Then, in its centenary year of 2025, the company published a six-year plan, Next Design 2030, whose core is an “asset transformation” — restructuring 20–30% of domestic production sites through alliances, M&A, contract manufacturing and internal consolidation — alongside a dividend payout target raised from 30% to 40% and a 6% ROE goal met partly by unwinding cross-shareholdings. Execution moved quickly: by May 2026 production had been scheduled to end at Kobe, Okoppe and Kawagoe, about 13% of the way to the target, while the Hong Kong base was closed and infant formula made fabless to clear loss-making overseas operations, leaving MBP exports as the growth line. In the year to March 2026 the group ran on three segments — dairy products, beverages and desserts, and feed and seed — with 5,844 employees and operating profit of $122.3M (¥18bn). A co-operative that began with one product, butter, now has to answer a question its founders never faced: not who sets the price of milk, but whether there will be enough dairy farmers, and enough people drinking it, to need the plants it built.